Navigation Links
A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
Date:2/26/2009

563 ccomfort@dresources.com emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
2. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
3. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
4. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
5. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
6. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkins Lymphoma
7. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
8. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
9. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Dec. 17 Reportlinker.com announces ... is available in its catalogue: ,, ... Pipeline Technology and Market Forecasts to ... ,, Negative Pressure Wound Therapy ... to 2016 ,, Summary ...
(Date:12/17/2009)... -- Connectyx Technologies Holding Group Inc. (Pink Sheets: ... distribution partnership with United States Medical Supply, a ... Supplies and Medications as well as Bladder Control ... Terms of the partnership were not disclosed, however ... adds to our growing distribution channel for MedFlash ...
(Date:12/17/2009)... -- Suneva Medical, a privately-held aesthetic medical device ... multi-million dollar line of credit facility with Western ... facility will be used to fund commercial support ... filler on the market today, as well as ... "Today Suneva Medical entered into a multi-million dollar ...
Breaking Medicine Technology:Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 2Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 3Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 4Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 5Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 6Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 3Americans United for Life Action Says the House Approved Bill to Promote Abortion Overseas is a Grave Injustice 48545 1Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 1Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 2Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 3Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 4Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 5Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 6After House Committee Chairs Meet on Health Reform Long Term Care Leaders Say Rescinding Bush Era Medicare Regulation Critical to Protecting Jobs Pr 48539 1After House Committee Chairs Meet on Health Reform Long Term Care Leaders Say Rescinding Bush Era Medicare Regulation Critical to Protecting Jobs Pr 48539 2After House Committee Chairs Meet on Health Reform Long Term Care Leaders Say Rescinding Bush Era Medicare Regulation Critical to Protecting Jobs Pr 48539 3
... May 14 Spherix Incorporated (Nasdaq: SPEX ), an innovator ... consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported results ... , , ... Created a wholly owned subsidiary, Biospherics Incorporated, for the ...
... DIEGO, May 14 TargeGen, Inc. today announced ... multi-center clinical trial of TG101348, an oral, potent, ... with myelofibrosis on May 7, 2009.(Logo: ... at six centers in the USA. The study ...
Other Medicine Technology:Spherix Reports First Quarter 2009 Earnings 2Spherix Reports First Quarter 2009 Earnings 3Spherix Reports First Quarter 2009 Earnings 4Spherix Reports First Quarter 2009 Earnings 5Spherix Reports First Quarter 2009 Earnings 6Spherix Reports First Quarter 2009 Earnings 7
(Date:12/17/2009)... -- Reportlinker.com announces that a new market ... ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ,, The ... health industry executives with strategically significant competitor ... development and implementation of effective marketing and ... ,, To establish a comprehensive, ...
(Date:12/17/2009)... DALLAS, Dec. 17 The following feature ... National Center for Policy Analysis: ,, People often ... spend on health care. After all, sickness cannot ... coverage to more than 60 percent of Americans. However, ... costs and still get the care you need. ...
(Date:12/17/2009)... National Council on Disability (NCD) will conduct ... 5150 Westheimer, Houston, TX, beginning at 8:30 a.m. on ... on Thursday, January 21, 2010. This meeting is open ... vital to hear from communities around the country on ... disabilities. This meeting will provide another opportunity for that ...
(Date:12/17/2009)... Jay and Maureen Neitz, the husband-and-wife team whose pioneering ... to treat vision disorders, as the inaugural recipients of ... The award is funded by a $1 million endowment ... Jay Pepose ,75 and Susan K. Feigenbaum ,74, his ... vision science. , The Neitzes, both of whom are ...
(Date:12/17/2009)... someday ease accompanying lung infections , , THURSDAY, Dec. 17 ... infected with the swine flu virus, and researchers say ... key to the severity of the illness appears to ... the immune system fight off germs and disease. Researchers ... at 10 Spanish hospitals last summer found the highest ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2
... Chain Drugstore Ltd. (NYSE: NPD ) ("China Nepstar" ... on the number of,directly operated stores, today announced that ... its ordinary share of US$0.06 per share, based,on its ... dividend is payable on,or around May 12th, 2008, to ...
... head-to-head with your child,can be more stacked than playing blackjack ... bedtime and, before you know it, she,ll be,whacking you upside ... I can,t stay up late to have more dessert and ... a back rub and two books before the,lights go out., ...
... 24 HeartWare Inc. (ASX: HTW),a developer and ... heart failure, today announced it has selected Allen ... and corporate communications.,Allen & Caron Inc has offices ... HeartWare Chief Executive Douglas Godshall said: "There is ...
... model (cell culture) research currently underway at the Peninsula Medical ... identify and develop therapies for the treatment of multiple tumours ... affecting a protein called merlin, which in turn cause cancers ... the brain. Schwann cells produce the sheaths that surround and ...
... ... Biodefense and Pandemic Fund, SAN DIEGO, March 24 ... Series B financing to advance the,clinical development of its best-in-class ... was led by Kleiner,Perkins, Caufield and Byers (KPCB). New investor ...
... for Funding Suspension After Trial Failures, ... Sun,opinion piece today ( http://www.baltimoresun.com/news/opinion/oped/bal -,op.aidsvaccine23mar23,0,3426636.story), AIDS ... costly HIV vaccine research funding and the,re- ... prevention,testing and treatment strategies., Co-authored by ...
Other Medicine News:Health News:China Nepstar Chain Drugstore Announces Dividend 2Health News:China Nepstar Chain Drugstore Announces Dividend 3Health News:HOW TO UNSPOIL YOUR CHILD FAST: Harvard Medical School Psychologist Writes Book to Guide and Motivate Parents and Support the Children's Defense Fund 2Health News:HeartWare Selects Allen & Caron for Investor Relations and Corporate Communications 2Health News:Research to lead to brain tumor therapies 2Health News:Research to lead to brain tumor therapies 3Health News:Trius Raises $30 Million in Series B Financing 2Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 2Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 3Health News:HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: